YSP Southeast Asia Holding Bhd (7178) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.130x

Based on the latest financial reports, YSP Southeast Asia Holding Bhd (7178) has a cash flow conversion efficiency ratio of 0.130x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM54.46 Million ≈ $13.67 Million USD) by net assets (RM417.87 Million ≈ $104.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

YSP Southeast Asia Holding Bhd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how YSP Southeast Asia Holding Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read YSP Southeast Asia Holding Bhd debt and liabilities for a breakdown of total debt and financial obligations.

YSP Southeast Asia Holding Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of YSP Southeast Asia Holding Bhd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Mukka Proteins Limited
NSE:MUKKA
-0.022x
Shanghai Shibei Hi-Tech Co Ltd B
SHG:900902
-0.011x
Wellell Inc
TW:4106
0.036x
Exagen Inc
NASDAQ:XGN
0.162x
MFC Asset Management Public Company Limited
BK:MFC
0.008x
Fintech Ecosystem Development Corp
NASDAQ:FEXD
-0.018x
Aker Technology Co Ltd
TWO:6174
0.024x
C3 Metals Inc
V:CCCM
-0.012x

Annual Cash Flow Conversion Efficiency for YSP Southeast Asia Holding Bhd (2012–2025)

The table below shows the annual cash flow conversion efficiency of YSP Southeast Asia Holding Bhd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see how much is YSP Southeast Asia Holding Bhd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 RM425.70 Million
≈ $106.88 Million
RM54.46 Million
≈ $13.67 Million
0.128x +5.26%
2024-12-31 RM409.02 Million
≈ $102.69 Million
RM49.71 Million
≈ $12.48 Million
0.122x +32.17%
2023-12-31 RM395.06 Million
≈ $99.19 Million
RM36.33 Million
≈ $9.12 Million
0.092x -29.17%
2022-12-31 RM372.16 Million
≈ $93.44 Million
RM48.31 Million
≈ $12.13 Million
0.130x -29.31%
2021-12-31 RM346.50 Million
≈ $87.00 Million
RM63.63 Million
≈ $15.98 Million
0.184x +593.57%
2020-12-31 RM342.60 Million
≈ $86.01 Million
RM9.07 Million
≈ $2.28 Million
0.026x -73.32%
2019-12-31 RM328.19 Million
≈ $82.40 Million
RM32.58 Million
≈ $8.18 Million
0.099x +54.77%
2018-12-31 RM315.05 Million
≈ $79.10 Million
RM20.20 Million
≈ $5.07 Million
0.064x -32.73%
2017-12-31 RM289.51 Million
≈ $72.69 Million
RM27.60 Million
≈ $6.93 Million
0.095x -37.56%
2016-12-31 RM274.41 Million
≈ $68.89 Million
RM41.90 Million
≈ $10.52 Million
0.153x +49.30%
2015-12-31 RM264.00 Million
≈ $66.28 Million
RM27.00 Million
≈ $6.78 Million
0.102x +74.59%
2014-12-31 RM239.00 Million
≈ $60.01 Million
RM14.00 Million
≈ $3.51 Million
0.059x -55.09%
2013-12-31 RM230.00 Million
≈ $57.75 Million
RM30.00 Million
≈ $7.53 Million
0.130x +71.10%
2012-12-31 RM223.00 Million
≈ $55.99 Million
RM17.00 Million
≈ $4.27 Million
0.076x --

About YSP Southeast Asia Holding Bhd

KLSE:7178 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$74.43 Million
RM296.46 Million MYR
Market Cap Rank
#20476 Global
#384 in Malaysia
Share Price
RM2.09
Change (1 day)
-0.95%
52-Week Range
RM2.03 - RM2.30
All Time High
RM2.95
About

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, an… Read more